nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Contents
|
|
|
|
34 |
2 |
p. vii-xi |
artikel |
2 |
Contributors
|
|
|
|
34 |
2 |
p. iii-v |
artikel |
3 |
Copyright
|
|
|
|
34 |
2 |
p. ii |
artikel |
4 |
Direct T-cell Inhibition and Agents Targeting T-cell Migration and Chemotaxis
|
Fernández-Ruiz, Mario |
|
|
34 |
2 |
p. 191-210 |
artikel |
5 |
Epidermal Growth Factor Receptor Inhibitors and Other Tyrosine Kinase Inhibitors for Solid Tumors
|
Ruiz-Camps, Isabel |
|
|
34 |
2 |
p. 257-270 |
artikel |
6 |
Fungal Infections Potentiated by Biologics
|
Davis, Matthew R. |
|
|
34 |
2 |
p. 389-411 |
artikel |
7 |
Hepatitis B Virus Reactivation Potentiated by Biologics
|
Ogawa, Eiichi |
|
|
34 |
2 |
p. 341-358 |
artikel |
8 |
Herpesvirus Infections Potentiated by Biologics
|
Ho, Dora Y. |
|
|
34 |
2 |
p. 311-339 |
artikel |
9 |
Infections Related to Biologics
|
Ho, Dora Y. |
|
|
34 |
2 |
p. xiii-xvi |
artikel |
10 |
Infections Related to Biologics
|
Leandro, Maria J. |
|
|
34 |
2 |
p. 161-178 |
artikel |
11 |
Infections Related to Biologics
|
Ho, Dora Y. |
|
|
34 |
2 |
p. i |
artikel |
12 |
Infectious Complications of Immune Checkpoint Inhibitors
|
Abers, Michael S. |
|
|
34 |
2 |
p. 235-243 |
artikel |
13 |
Infectious Complications of Tyrosine Kinase Inhibitors in Hematological Malignancies
|
Kin, Andrew |
|
|
34 |
2 |
p. 245-256 |
artikel |
14 |
Infectious Disease Clinics of North America
|
|
|
|
34 |
2 |
p. xii |
artikel |
15 |
Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition
|
Liu, Anne Y. |
|
|
34 |
2 |
p. 211-234 |
artikel |
16 |
Infectious Risks Associated with Biologics Targeting Janus Kinase-Signal Transducer and Activator of Transcription Signaling and Complement Pathway for Inflammatory Diseases
|
Benamu, Esther |
|
|
34 |
2 |
p. 271-310 |
artikel |
17 |
JC Polyomavirus Infection Potentiated by Biologics
|
Multani, Ashrit |
|
|
34 |
2 |
p. 359-388 |
artikel |
18 |
Mycobacterial Infections Potentiated by Biologics
|
Calabrese, Cassandra |
|
|
34 |
2 |
p. 413-423 |
artikel |
19 |
Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines
|
Shoor, Stanford |
|
|
34 |
2 |
p. 179-189 |
artikel |
20 |
Vaccinations and Biologics
|
Hsiao, Betty |
|
|
34 |
2 |
p. 425-450 |
artikel |